Baixar Oncology Nursing Drug Handbook - v3.5.13

Faça download e compartilhe Oncology Nursing Drug Handbook - v3.5.13, um dos apresentados APLICATIVOS na categoria Medicina.
Além disso, alguns outros APLICATIVOS que você pode baixar como Patchwork, Inject App, Jan Aushadhi Sugam (BPPI), Medical Dictionary Free & Offline - Diseases, iDentist Dental practice management, Medical PG, FMGE Preparation - PrepLadder. Se você estiver satisfeito com Oncology Nursing Drug Handbook - v3.5.13.

Lançado por Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 é um dos melhores e melhores aplicativos gratuitos para celular disponíveis atualmente. Localizado na categoria Medicina da loja de aplicativos.

O sistema operacional mínimo para Oncology Nursing Drug Handbook - v3.5.13 é Android 5.0+ e superior. Portanto, você deve atualizar seu telefone, se ainda não o fez.

No APKDroid, você obterá Oncology Nursing Drug Handbook - v3.5.13 download gratuito do APK, sendo a versão mais recente 3.5.13, data de publicação 2020-06-25, o tamanho do arquivo é 8.4 MB.De acordo com as estatísticas da Google Play Store, há cerca de 1000 downloads. Aplicativos baixados ou instalados individualmente no Android podem ser atualizados se você desejar. Atualize seus aplicativos também. Concede a você acesso aos recursos mais recentes e melhora a segurança e estabilidade do aplicativo. Aproveite agora !!!

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity